Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Intraarterial Yttrium-90 Microsphere Therapy for Primary and Secondary Liver Tumors :A-7-year Experience of a Single Institution.

Fani Bozkurt, Bilge SALANCI, Bora PEYNIRCIOGLU, Gonca ELDEM, Barbaros CIL and Omer UGUR
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 474;
Fani Bozkurt
1Hacettepe University Faculty of Medicine Department of Nuclear Medicine Ankara Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bilge SALANCI
1Hacettepe University Faculty of Medicine Department of Nuclear Medicine Ankara Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bora PEYNIRCIOGLU
2Hacettepe University Faculty of Medicine Department of Radiology Ankara Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gonca ELDEM
2Hacettepe University Faculty of Medicine Department of Radiology Ankara Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbaros CIL
2Hacettepe University Faculty of Medicine Department of Radiology Ankara Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omer UGUR
1Hacettepe University Faculty of Medicine Department of Nuclear Medicine Ankara Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 474

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Fani Bozkurt1,
  2. Bilge SALANCI1,
  3. Bora PEYNIRCIOGLU2,
  4. Gonca ELDEM2,
  5. Barbaros CIL2 and
  6. Omer UGUR1
  1. 1Hacettepe University Faculty of Medicine Department of Nuclear Medicine Ankara Turkey
  2. 2Hacettepe University Faculty of Medicine Department of Radiology Ankara Turkey

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to January 2023

AbstractFullPdf
May 20161000
Jun 201618400
Jul 20161700
Aug 2016800
Sep 20161300
Oct 20161700
Nov 20161200
Dec 20161000
Jan 2017400
Feb 2017600
Mar 2017400
Apr 2017500
May 2017800
Jun 2017200
Jul 2017200
Aug 2017300
Sep 2017600
Oct 2017500
Nov 20171300
Jan 2018200
Feb 2018100
Apr 2018100
May 2018100
Jun 2018400
Jul 2018400
Aug 2018800
Sep 2018100
Oct 2018100
Nov 2018400
Jan 2019100
Mar 2019100
Apr 2019100
Jun 2019100
Oct 2019200
Nov 2019200
Dec 2019100
Feb 2020500
Mar 20201600
Apr 2020900
May 2020900
Jun 2020400
Jul 2020300
Aug 20201100
Sep 20202400
Oct 20202200
Nov 20201800
Dec 2020900
Jan 2021200
Feb 20211100
Mar 2021800
Apr 20214800
May 2021600
Jun 2021500
Jul 20211600
Aug 20213300
Sep 20211300
Oct 20213000
Nov 20216100
Dec 20214100
Jan 20226800
Feb 20222400
Mar 20222800
Apr 20221600
May 20222800
Jun 2022400
Jul 2022100
Aug 2022200
Sep 2022300
Oct 2022100
Nov 2022100
Dec 2022200
Jan 2023600
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Intraarterial Yttrium-90 Microsphere Therapy for Primary and Secondary Liver Tumors :A-7-year Experience of a Single Institution.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Intraarterial Yttrium-90 Microsphere Therapy for Primary and Secondary Liver Tumors :A-7-year Experience of a Single Institution.
Fani Bozkurt, Bilge SALANCI, Bora PEYNIRCIOGLU, Gonca ELDEM, Barbaros CIL, Omer UGUR
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 474;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Intraarterial Yttrium-90 Microsphere Therapy for Primary and Secondary Liver Tumors :A-7-year Experience of a Single Institution.
Fani Bozkurt, Bilge SALANCI, Bora PEYNIRCIOGLU, Gonca ELDEM, Barbaros CIL, Omer UGUR
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 474;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

Receptor, others

  • Therapeutic efficacy of α-emitter meta-211At-astato-benzylguanidine (MABG) in a pheochromocytoma model
  • DOTAZOL as novel bone seeking compound for Ga-68 PET diagnosis and Lu-177 endoradiotherapy of bone metastases: From preclinical to first human results
  • I131-MIBG treatment revisited: How important is scheduling when combined with external beam irradiation?
Show more Receptor, others

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire